Mesenchymal Stem Cells in the Adult Human Liver: Hype or Hope?
Chronic liver diseases constitute a significant economic, social, and biomedical burden. Among commonly adopted approaches, only organ transplantation can radically help patients with end-stage liver pathologies. Cell therapy with hepatocytes as a treatment for chronic liver disease has demonstrated...
Main Authors: | Irina V. Kholodenko, Leonid K. Kurbatov, Roman V. Kholodenko, Garik V. Manukyan, Konstantin N. Yarygin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-09-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/10/1127 |
Similar Items
-
Combination therapy of Juzentaihoto and mesenchymal stem cells attenuates liver damage and regresses fibrosis in mice
by: Takahiro Iwasawa, et al.
Published: (2021-12-01) -
Immunomodulatory Nature and Site Specific Affinity of Mesenchymal Stem Cells: a Hope in Cell Therapy
by: Parisa Lotfinegad, et al.
Published: (2014-03-01) -
Individual heterogeneity screened umbilical cord-derived mesenchymal stromal cells with high Treg promotion demonstrate improved recovery of mouse liver fibrosis
by: Yuanyuan Xie, et al.
Published: (2021-06-01) -
Immunomodulatory effect of mesenchymal stem cells
by: Luciana Cavalheiro Marti, et al.
Published: (2011-06-01) -
Transition of clinical and basic studies on liver cirrhosis treatment using cells to seek the best treatment
by: Shuji Terai, et al.
Published: (2021-09-01)